Morie A. Gertz, MD of Mayo Clinic discusses Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Morie A. Gertz, MD of Mayo Clinic discusses Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.